Back

ATF2 phosphorylation is a key event in neuronal apoptosis, linking the DLK/LZK kinase cascade to JUN upregulation

Gomez Deza, J.; Nebiyou, M.; Alkaslasi, M. R.; El Touny, L. H.; Slavutsky, A. L.; Ashby, N.; Cheng, K.; Le Pichon, C. E.

2023-09-28 neuroscience
10.1101/2023.09.27.559856 bioRxiv
Show abstract

Apoptotic neuron death is a key feature of neurodegenerative disease. Considerable efforts have been made to target this pathway but the molecular mechanisms remain incompletely understood. Here, we conducted an unbiased whole genome CRISPR inhibition screen in human neurons to discover genes required for their death and identified known targets including the kinase MAP3K12 (DLK) and the transcription factor JUN. In addition, this screen revealed a potential role for the transcription factor ATF2. We demonstrate that ATF2 phosphorylation by MAP3 kinases is the core driver of the pro-apoptotic transcriptional response. Surprisingly, JUN phosphorylation is not required for apoptosis. However, the phosphorylation of ATF2 and upregulation of JUN expression are crucial. ATF2 therefore converts the kinase signal into a transcriptional response. Inhibiting ATF2 in cultured human neurons prevents cell death. Notably we show that ATF2 knockdown is neuroprotective in injury models in vivo. Thus, ATF2 provides a promising new target for a wide range of neurodegenerative disorders.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Cell Death & Disease
126 papers in training set
Top 0.1%
22.9%
2
Nature Communications
4913 papers in training set
Top 22%
8.5%
3
Cell Death & Differentiation
48 papers in training set
Top 0.1%
4.9%
4
eLife
5422 papers in training set
Top 19%
4.4%
5
Brain
154 papers in training set
Top 1%
4.4%
6
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 17%
4.0%
7
Acta Neuropathologica
51 papers in training set
Top 0.3%
3.6%
50% of probability mass above
8
Cell Death Discovery
51 papers in training set
Top 0.2%
3.6%
9
Cell Reports
1338 papers in training set
Top 17%
3.1%
10
Scientific Reports
3102 papers in training set
Top 43%
2.8%
11
Neurobiology of Disease
134 papers in training set
Top 2%
2.1%
12
EMBO Molecular Medicine
85 papers in training set
Top 1%
1.9%
13
Molecular Therapy
71 papers in training set
Top 2%
1.4%
14
Brain Communications
147 papers in training set
Top 2%
1.2%
15
Science Advances
1098 papers in training set
Top 22%
1.2%
16
Molecular Psychiatry
242 papers in training set
Top 2%
1.2%
17
Neuron
282 papers in training set
Top 7%
1.0%
18
iScience
1063 papers in training set
Top 24%
1.0%
19
PLOS Biology
408 papers in training set
Top 15%
1.0%
20
Aging Cell
144 papers in training set
Top 3%
0.9%
21
Theranostics
33 papers in training set
Top 1%
0.9%
22
Experimental Neurology
57 papers in training set
Top 1%
0.8%
23
Molecular & Cellular Proteomics
158 papers in training set
Top 2%
0.8%
24
JCI Insight
241 papers in training set
Top 7%
0.8%
25
Alzheimer's & Dementia
143 papers in training set
Top 3%
0.8%
26
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.8%
27
EMBO Reports
88 papers in training set
Top 0.6%
0.8%
28
Cells
232 papers in training set
Top 6%
0.8%
29
Redox Biology
64 papers in training set
Top 1%
0.7%
30
NAR Molecular Medicine
18 papers in training set
Top 0.3%
0.7%